Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism
Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress r...
Saved in:
| Published in | Science (American Association for the Advancement of Science) Vol. 319; no. 5869; pp. 1536 - 1539 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Washington, DC
American Association for the Advancement of Science
14.03.2008
The American Association for the Advancement of Science |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist (LY686017; n = 25) or placebo (n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well-being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism. |
|---|---|
| AbstractList | Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist (LY686017; n = 25) or placebo (n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well-being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism. Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist (LY686017; n = 25) or placebo (n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well-being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism. [PUBLICATION ABSTRACT] Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist (LY686017; n = 25) or placebo ( n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well-being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism. Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist (LY686017; n = 25) or placebo (n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well-being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism.Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor (NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist (LY686017; n = 25) or placebo (n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well-being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism. |
| Author | Herion, David Gilman, Jodi Heilig, Markus Kielbasa, William Tauscher, Johannes T Brandt, John E Hersh, Jacqueline Peng, Xiaomei Rawlings, Robert Hommer, Daniel Geyer, Christopher Thorsell, Annika Gehlert, Donald R George, David T Hunt, Stephen P |
| Author_xml | – sequence: 1 fullname: George, David T – sequence: 2 fullname: Gilman, Jodi – sequence: 3 fullname: Hersh, Jacqueline – sequence: 4 fullname: Thorsell, Annika – sequence: 5 fullname: Herion, David – sequence: 6 fullname: Geyer, Christopher – sequence: 7 fullname: Peng, Xiaomei – sequence: 8 fullname: Kielbasa, William – sequence: 9 fullname: Rawlings, Robert – sequence: 10 fullname: Brandt, John E – sequence: 11 fullname: Gehlert, Donald R – sequence: 12 fullname: Tauscher, Johannes T – sequence: 13 fullname: Hunt, Stephen P – sequence: 14 fullname: Hommer, Daniel – sequence: 15 fullname: Heilig, Markus |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20192204$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18276852$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-101851$$DView record from Swedish Publication Index |
| BookMark | eNqFks1v1DAQxS1URLeFMycgQoJbqD8T-7gq5UOqAEHL1XK8k62XrJ3aiVD_exwlrFAl1JNlze_Zb2beCTrywQNCzwl-RwitzpJ14C3ki2CSsEdoRbASpaKYHaEVxqwqJa7FMTpJaYdxrin2BB0TSetKCrpCF19gjOGX884XpPgOFvohxGLtB7MN3qV9YVJhim8hJdd0UFzdQDT9XdFOUGfDTegy9BQ9bk2X4NlynqLrDxdX55_Ky68fP5-vL0srlBhKslFsw4zlRrUcDFVtK2RtFdlwDoK3tFJNsyFWMsZqrqQRUIEAAlRgyYhip6ic302_oR8b3Ue3N_FOB-P0e_dzrUPc6s6NmmAiBcn825nvY7gdIQ1675KFrjMewph0jZniomYPgrwWcnL1IEhxJSpGpq9f3wN3YYw-T0dTwoSinNQZerlAY7OHzaGfv_vJwJsFMMmaro3GW5cOHMVEUYp55sTM2Zg3FaHV1g1mcMEP0bguz0NPedFLXvSSl6w7u6c7WPiv4sWs2KUclH-cYJG7mvp-NddbE7TZxuz2-kf2yTCWdY6iYn8AREzTzg |
| CODEN | SCIEAS |
| CitedBy_id | crossref_primary_10_1517_13543776_2010_495121 crossref_primary_10_1038_npp_2012_261 crossref_primary_10_1111_j_1369_1600_2011_00419_x crossref_primary_10_1016_j_neuroscience_2019_06_023 crossref_primary_10_1038_npp_2010_253 crossref_primary_10_1111_gbb_12349 crossref_primary_10_1038_nrd2556 crossref_primary_10_1523_JNEUROSCI_2736_13_2014 crossref_primary_10_1007_s00213_016_4504_6 crossref_primary_10_1038_npp_2014_306 crossref_primary_10_1038_mp_2017_102 crossref_primary_10_1016_j_alcohol_2009_08_003 crossref_primary_10_1016_S0140_6736_19_31775_1 crossref_primary_10_1016_j_psyneuen_2016_10_011 crossref_primary_10_1007_s11064_019_02944_9 crossref_primary_10_1111_adb_12494 crossref_primary_10_1152_physrev_00031_2013 crossref_primary_10_1080_09638237_2019_1644492 crossref_primary_10_1016_j_brainres_2020_146729 crossref_primary_10_1152_physrev_00013_2008 crossref_primary_10_1097_FBP_0b013e32832ec594 crossref_primary_10_1016_j_drugalcdep_2017_09_022 crossref_primary_10_1016_j_neuroimage_2011_02_004 crossref_primary_10_1111_joim_13636 crossref_primary_10_1111_j_1369_1600_2009_00194_x crossref_primary_10_1016_j_bmcl_2010_01_065 crossref_primary_10_1016_j_physbeh_2016_02_024 crossref_primary_10_1126_sciadv_aaz1050 crossref_primary_10_1038_npp_2009_65 crossref_primary_10_1016_j_neuron_2012_09_026 crossref_primary_10_1111_j_1530_0277_2012_01923_x crossref_primary_10_1111_febs_16400 crossref_primary_10_1002_ejp_1027 crossref_primary_10_1038_nrn2361 crossref_primary_10_4049_jimmunol_1100721 crossref_primary_10_1111_jnc_15301 crossref_primary_10_1016_j_euroneuro_2010_04_003 crossref_primary_10_1016_j_euroneuro_2011_12_005 crossref_primary_10_1111_j_1471_4159_2008_05596_x crossref_primary_10_1007_s00213_021_05814_x crossref_primary_10_1016_j_pharmthera_2009_11_002 crossref_primary_10_1016_j_ynstr_2018_08_003 crossref_primary_10_1177_0269881108100255 crossref_primary_10_3390_pharmaceutics11090443 crossref_primary_10_1111_j_1369_1600_2010_00282_x crossref_primary_10_1007_s00213_010_2163_6 crossref_primary_10_4199_C00082ED1V01Y201304NPE004 crossref_primary_10_1517_13543780903379530 crossref_primary_10_1111_j_1530_0277_2010_01363_x crossref_primary_10_1016_j_pain_2013_04_020 crossref_primary_10_1038_nrd2828 crossref_primary_10_2217_pgs_2016_0193 crossref_primary_10_1113_jphysiol_2010_188367 crossref_primary_10_1111_bph_15160 crossref_primary_10_1016_j_neuropharm_2021_108748 crossref_primary_10_1007_s00213_018_4976_7 crossref_primary_10_1371_journal_pone_0012527 crossref_primary_10_1021_cr300095f crossref_primary_10_1016_j_pbb_2012_07_007 crossref_primary_10_1007_s00213_011_2201_z crossref_primary_10_1016_j_neubiorev_2019_05_014 crossref_primary_10_1111_adb_12349 crossref_primary_10_1002_ajmg_b_32241 crossref_primary_10_1002_hbm_26249 crossref_primary_10_1007_s00726_014_1736_9 crossref_primary_10_1111_adb_12187 crossref_primary_10_1111_j_1749_6632_2010_05832_x crossref_primary_10_1186_s12974_017_0813_x crossref_primary_10_1016_j_ejphar_2008_10_001 crossref_primary_10_1038_npp_2013_309 crossref_primary_10_1016_j_neulet_2010_11_049 crossref_primary_10_1177_0269881116668592 crossref_primary_10_3389_fnins_2014_00288 crossref_primary_10_1517_14740338_2013_804059 crossref_primary_10_1007_s00213_010_1775_1 crossref_primary_10_1124_jpet_113_210799 crossref_primary_10_1111_j_1365_2036_2011_04958_x crossref_primary_10_1517_13543784_2014_954037 crossref_primary_10_1111_acer_13507 crossref_primary_10_1111_bcp_12004 crossref_primary_10_1002_jcph_120 crossref_primary_10_1146_annurev_clinpsy_121208_131441 crossref_primary_10_1016_j_euroneuro_2010_11_012 crossref_primary_10_1038_npp_2016_61 crossref_primary_10_1016_j_biopsych_2012_12_027 crossref_primary_10_1111_j_1360_0443_2010_02995_x crossref_primary_10_1124_jpet_110_170969 crossref_primary_10_1111_j_1369_1600_2012_00454_x crossref_primary_10_1002_jeab_114 crossref_primary_10_1016_j_npep_2011_01_003 crossref_primary_10_1016_j_drugalcdep_2012_12_017 crossref_primary_10_1111_bph_13280 crossref_primary_10_1021_cn300013p crossref_primary_10_1038_npp_2015_142 crossref_primary_10_1016_j_conb_2013_05_005 crossref_primary_10_1177_0269881115596155 crossref_primary_10_1176_appi_ajp_2010_08101500 crossref_primary_10_1111_adb_12288 crossref_primary_10_1111_jnc_15343 crossref_primary_10_1007_s00213_011_2263_y crossref_primary_10_1007_s00213_014_3665_4 crossref_primary_10_1016_j_neulet_2010_03_051 crossref_primary_10_1093_ijnp_pyu030 crossref_primary_10_1007_s11064_024_04238_1 crossref_primary_10_3390_molecules24244460 crossref_primary_10_1177_0269881111425969 crossref_primary_10_1007_s13311_019_00828_y crossref_primary_10_1176_foc_9_1_foc79 crossref_primary_10_1016_j_addicn_2024_100174 crossref_primary_10_1177_10738584080140050201 crossref_primary_10_1111_j_1601_183X_2012_00787_x crossref_primary_10_1152_jn_00883_2014 crossref_primary_10_1007_s13273_012_0024_6 crossref_primary_10_1016_j_pbb_2015_10_003 crossref_primary_10_1016_S0084_3970_08_79035_2 crossref_primary_10_1038_npp_2016_214 crossref_primary_10_1016_j_cobeha_2016_10_006 crossref_primary_10_1111_adb_12150 crossref_primary_10_1007_s12264_013_1350_y crossref_primary_10_1177_1744806917727657 crossref_primary_10_1016_j_neuropharm_2009_08_021 crossref_primary_10_1017_S1461145712001678 crossref_primary_10_1016_j_biopsych_2023_08_024 crossref_primary_10_3762_bjoc_20_94 crossref_primary_10_1038_ngw1811 crossref_primary_10_1016_j_drugalcdep_2021_108564 crossref_primary_10_1111_j_1369_1600_2008_00127_x crossref_primary_10_1038_tp_2015_92 crossref_primary_10_1159_000362838 crossref_primary_10_1002_syn_20677 crossref_primary_10_3390_brainsci10020067 crossref_primary_10_3389_fgene_2018_00513 crossref_primary_10_1111_j_1530_0277_2009_00988_x crossref_primary_10_1111_acer_14167 crossref_primary_10_1196_annals_1418_007 |
| Cites_doi | 10.1080/09595230601036960 10.1037/0003-066X.41.7.765 10.1001/archpsyc.59.12.1162 10.1007/s002130050498 10.1016/S0140-6736(02)11403-6 10.1126/science.281.5383.1640 10.15288/jsa.2003.64.120 10.1016/j.tins.2007.06.006 10.1016/j.biopsych.2005.03.029 10.1016/S0028-3908(02)00295-2 10.1007/s002130100919 10.1126/science.1135926 10.1111/j.1530-0277.2007.00406.x 10.1016/j.tips.2003.09.011 10.1097/01.ALC.0000141637.01925.F6 10.1037/0033-295X.97.2.147 10.1038/32904 10.1038/35012069 10.1523/JNEUROSCI.22-18-07856.2002 10.1016/j.pharmthera.2006.02.001 10.1016/0166-2236(83)90149-2 |
| ContentType | Journal Article |
| Copyright | Copyright 2008 American Association for the Advancement of Science 2008 INIST-CNRS Copyright © 2008, American Association for the Advancement of Science |
| Copyright_xml | – notice: Copyright 2008 American Association for the Advancement of Science – notice: 2008 INIST-CNRS – notice: Copyright © 2008, American Association for the Advancement of Science |
| DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QF 7QG 7QL 7QP 7QQ 7QR 7SC 7SE 7SN 7SP 7SR 7SS 7T7 7TA 7TB 7TK 7TM 7U5 7U9 8BQ 8FD C1K F28 FR3 H8D H8G H94 JG9 JQ2 K9. KR7 L7M L~C L~D M7N P64 RC3 7S9 L.6 7X8 ADTPV AOWAS DG8 |
| DOI | 10.1126/science.1153813 |
| DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Aluminium Industry Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Ceramic Abstracts Chemoreception Abstracts Computer and Information Systems Abstracts Corrosion Abstracts Ecology Abstracts Electronics & Communications Abstracts Engineered Materials Abstracts Entomology Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Materials Business File Mechanical & Transportation Engineering Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Solid State and Superconductivity Abstracts Virology and AIDS Abstracts METADEX Technology Research Database Environmental Sciences and Pollution Management ANTE: Abstracts in New Technology & Engineering Engineering Research Database Aerospace Database Copper Technical Reference Library AIDS and Cancer Research Abstracts Materials Research Database ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Civil Engineering Abstracts Advanced Technologies Database with Aerospace Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic SwePub SwePub Articles SWEPUB Linköpings universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Technology Research Database Computer and Information Systems Abstracts – Academic Mechanical & Transportation Engineering Abstracts Nucleic Acids Abstracts ProQuest Computer Science Collection Computer and Information Systems Abstracts ProQuest Health & Medical Complete (Alumni) Materials Business File Environmental Sciences and Pollution Management Aerospace Database Copper Technical Reference Library Engineered Materials Abstracts Genetics Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Advanced Technologies Database with Aerospace ANTE: Abstracts in New Technology & Engineering Civil Engineering Abstracts Aluminium Industry Abstracts Virology and AIDS Abstracts Electronics & Communications Abstracts Ceramic Abstracts Ecology Abstracts Neurosciences Abstracts METADEX Biotechnology and BioEngineering Abstracts Computer and Information Systems Abstracts Professional Entomology Abstracts Animal Behavior Abstracts Solid State and Superconductivity Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Corrosion Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | Materials Research Database MEDLINE AGRICOLA CrossRef Genetics Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Biology Public Health |
| EISSN | 1095-9203 |
| EndPage | 1539 |
| ExternalDocumentID | oai_DiVA_org_liu_101851 1443730991 18276852 20192204 10_1126_science_1153813 20053591 US201300870759 |
| Genre | Randomized Controlled Trial Journal Article Research Support, N.I.H., Intramural Feature |
| GrantInformation_xml | – fundername: Intramural NIH HHS |
| GroupedDBID | --- --Z -DZ -ET -~X .-4 ..I .55 .DC .GJ .GO .HR 0-V 08G 0B8 0R~ 0WA 123 186 18M 2FS 2KS 2WC 2XV 34G 36B 39C 3EH 3R3 3V. 4.4 41~ 42X 4R4 53G 5RE 63O 66. 68V 692 6OB 6TJ 79B 7X2 7X7 7XC 7~K 85S 88A 88E 88I 8AF 8CJ 8F7 8FE 8FG 8FH 8FI 8FJ 8G5 8GL 8WZ 97F A6W AABCJ AACGO AADHG AAFWJ AAIKC AAJYS AAKAS AAMNW AANCE AAWTO AAYJJ AAYOK ABBHK ABCQX ABDBF ABDEX ABEFU ABIVO ABJCF ABOCM ABPLY ABPMR ABPPZ ABPTK ABQIJ ABTAH ABTLG ABUWG ABWJO ABZEH ACBEA ACBEC ACGFO ACGFS ACGOD ACIWK ACMJI ACNCT ACPRK ACQAM ACQOY ACTDY ADBBV ADDRP ADMHC ADULT ADZCM ADZLD AEGBM AENEX AETEA AEUPB AEXZC AFCHL AFDAS AFFDN AFFNX AFHKK AFKRA AFOSN AFQFN AFRAH AGCDD AGFXO AGNAY AGSOS AHMBA AIDAL AIDUJ AJGZS AJUXI ALMA_UNASSIGNED_HOLDINGS ALSLI ANJGP ARALO ARAPS ASPBG ATCPS AVWKF AZQEC B-7 BBNVY BBWZM BCU BEC BENPR BGLVJ BHPHI BKF BKNYI BKSAR BLC BPHCQ BVXVI C2- C45 C51 CCPQU CJNVE CS3 D0S D1I D1J D1K DB2 DCCCD DNJUQ DOOOF DU5 DWIUU DWQXO D~A EAU EBS EGS EJD EMOBN ESX EWM EX3 F20 F5P FA8 FBQ FEDTE FYUFA G8K GICCO GNUQQ GUQSH GX1 HCIFZ HGD HMCUK HQ3 HTVGU HVGLF HZ~ I.T IAG IAO IBG IEA IEP IER IGG IGS IH2 IHR INH INR IOF IOV IPC IPO IPY ISE ISN ISR ITC J5H J9C JAAYA JBMMH JCF JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST K-O K6- K9- KB. KCC KQ8 L6V L7B LK5 LK8 LPU LSO LU7 M0K M0L M0P M0R M1P M2O M2P M2Q M7P M7R M7S MQT MVM N4W N9A NEJ NHB O9- OCB OFXIZ OGEVE OK1 OMK OVD P-O P2P P62 PATMY PCBAR PDBOC PK8 PQQKQ PROAC PSQYO PTHSS PV9 PYCSY PZZ QJJ QS- R05 RHF RHI RNS RXW RZL SA0 SC5 SJFOW SJN SKT TAE TEORI TN5 TWZ UBW UBY UCV UHB UHU UKHRP UKR UMD UNMZH UQL USG VOH VQA VVN WH7 WI4 WOQ WOW X7L X7M XFK XIH XJF XKJ XOL XZL Y6R YCJ YJ6 YK4 YKV YNT YOJ YR2 YRY YSQ YV5 YWH YXB YYP YYQ YZZ ZA5 ZCA ZCF ZCG ZE2 ZGI ZKG ZVL ZVM ZXP ZY4 ~02 ~G0 ~H1 ~KM ~ZZ ABDQB ABJNI ABXSQ ACHIC ACUHS ADQXQ ADUKH ADXHL AFBNE ALIPV AQVQM IPSME YR5 AAYXX CITATION ABDPE AEUYN AFQQW IQODW PHGZM PHGZT PJZUB PPXIY PQEDU PQGLB CGR CUY CVF ECM EIF NPM UIG 7QF 7QG 7QL 7QP 7QQ 7QR 7SC 7SE 7SN 7SP 7SR 7SS 7T7 7TA 7TB 7TK 7TM 7U5 7U9 8BQ 8FD C1K F28 FR3 H8D H8G H94 JG9 JQ2 K9. KR7 L7M L~C L~D M7N P64 RC3 7S9 L.6 7X8 ADTPV AOWAS DG8 |
| ID | FETCH-LOGICAL-c595t-1d93d3ac4a9f4ea29ff587c91d44e54f269bbd1c83337498a5e6e5e1e25083193 |
| ISSN | 0036-8075 1095-9203 |
| IngestDate | Thu Aug 21 07:06:49 EDT 2025 Mon Jul 21 11:49:45 EDT 2025 Fri Jul 11 14:01:55 EDT 2025 Wed Jul 30 10:42:25 EDT 2025 Fri Jul 25 10:54:20 EDT 2025 Thu Apr 03 07:06:43 EDT 2025 Mon Jul 21 09:16:10 EDT 2025 Tue Jul 01 02:03:31 EDT 2025 Thu Apr 24 23:04:50 EDT 2025 Thu Jul 03 21:21:05 EDT 2025 Wed Dec 27 19:43:12 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5869 |
| Keywords | NK1 Tachykinin receptor Alcoholism Rodentia Central nervous system Encephalon Vertebrata Mammalia Treatment Mouse Animal Dependence Antagonist Mechanism of action Biological receptor |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c595t-1d93d3ac4a9f4ea29ff587c91d44e54f269bbd1c83337498a5e6e5e1e25083193 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 18276852 |
| PQID | 213592417 |
| PQPubID | 1256 |
| PageCount | 4 |
| ParticipantIDs | swepub_primary_oai_DiVA_org_liu_101851 proquest_miscellaneous_70394573 proquest_miscellaneous_47588333 proquest_miscellaneous_20656311 proquest_journals_213592417 pubmed_primary_18276852 pascalfrancis_primary_20192204 crossref_citationtrail_10_1126_science_1153813 crossref_primary_10_1126_science_1153813 jstor_primary_20053591 fao_agris_US201300870759 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-03-14 |
| PublicationDateYYYYMMDD | 2008-03-14 |
| PublicationDate_xml | – month: 03 year: 2008 text: 2008-03-14 day: 14 |
| PublicationDecade | 2000 |
| PublicationPlace | Washington, DC |
| PublicationPlace_xml | – name: Washington, DC – name: United States – name: Washington |
| PublicationTitle | Science (American Association for the Advancement of Science) |
| PublicationTitleAlternate | Science |
| PublicationYear | 2008 |
| Publisher | American Association for the Advancement of Science The American Association for the Advancement of Science |
| Publisher_xml | – name: American Association for the Advancement of Science – name: The American Association for the Advancement of Science |
| References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_10_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 (e_1_3_2_15_2) 2004; 174 |
| References_xml | – ident: e_1_3_2_7_2 doi: 10.1080/09595230601036960 – ident: e_1_3_2_18_2 – ident: e_1_3_2_3_2 doi: 10.1037/0003-066X.41.7.765 – ident: e_1_3_2_21_2 doi: 10.1001/archpsyc.59.12.1162 – ident: e_1_3_2_4_2 doi: 10.1007/s002130050498 – ident: e_1_3_2_20_2 – ident: e_1_3_2_2_2 doi: 10.1016/S0140-6736(02)11403-6 – ident: e_1_3_2_27_2 doi: 10.1126/science.281.5383.1640 – ident: e_1_3_2_24_2 doi: 10.15288/jsa.2003.64.120 – ident: e_1_3_2_8_2 doi: 10.1016/j.tins.2007.06.006 – ident: e_1_3_2_12_2 doi: 10.1016/j.biopsych.2005.03.029 – ident: e_1_3_2_10_2 doi: 10.1016/S0028-3908(02)00295-2 – ident: e_1_3_2_25_2 doi: 10.1007/s002130100919 – ident: e_1_3_2_22_2 doi: 10.1126/science.1135926 – ident: e_1_3_2_23_2 doi: 10.1111/j.1530-0277.2007.00406.x – ident: e_1_3_2_9_2 doi: 10.1016/j.tips.2003.09.011 – ident: e_1_3_2_29_2 – ident: e_1_3_2_16_2 doi: 10.1097/01.ALC.0000141637.01925.F6 – ident: e_1_3_2_26_2 doi: 10.1037/0033-295X.97.2.147 – ident: e_1_3_2_17_2 – ident: e_1_3_2_14_2 doi: 10.1038/32904 – ident: e_1_3_2_11_2 doi: 10.1038/35012069 – ident: e_1_3_2_6_2 doi: 10.1523/JNEUROSCI.22-18-07856.2002 – ident: e_1_3_2_5_2 doi: 10.1016/j.pharmthera.2006.02.001 – ident: e_1_3_2_19_2 – ident: e_1_3_2_28_2 doi: 10.1016/0166-2236(83)90149-2 – volume: 174 start-page: 539 year: 2004 ident: e_1_3_2_15_2 publication-title: Psychopharmacology (Berlin) – ident: e_1_3_2_13_2 |
| SSID | ssj0009593 |
| Score | 2.3632205 |
| Snippet | Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in... |
| SourceID | swepub proquest pubmed pascalfrancis crossref jstor fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1536 |
| SubjectTerms | Addictive behaviors Adult Adult and adolescent clinical studies Aged alcohol abuse Alcohol drinking Alcohol Drinking - drug therapy Alcohol Education Alcohol related disorders Alcoholic beverages Alcoholism Alcoholism - drug therapy Alcoholism and acute alcohol poisoning Alcohols Animals antagonists Behavior, Addictive - drug therapy Biological and medical sciences brain Brain - drug effects Brain - physiology cortisol Craving Drug therapy Emotions - drug effects Ethanol - administration & dosage Ethanol - pharmacology Female Hormones Humans Hydrocortisone - blood Magnetic Resonance Imaging Male Medical sciences Mice Mice, Inbred C57BL Middle Aged Neurokinin-1 Receptor Antagonists Neurology Neurotransmitters patients Placebos Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Public health Pyridines - administration & dosage Pyridines - pharmacology Pyridines - therapeutic use Receptors Receptors, Neurokinin-1 - deficiency Receptors, Neurokinin-1 - genetics Receptors, Neurokinin-1 - physiology Relapse sedatives stress response therapeutics Toxicology Triazoles - administration & dosage Triazoles - pharmacology Triazoles - therapeutic use |
| Title | Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism |
| URI | https://www.jstor.org/stable/20053591 https://www.ncbi.nlm.nih.gov/pubmed/18276852 https://www.proquest.com/docview/213592417 https://www.proquest.com/docview/20656311 https://www.proquest.com/docview/47588333 https://www.proquest.com/docview/70394573 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-101851 |
| Volume | 319 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF6loEq9VIWW4tJSH6qKCgVlX7b3aCAkRUAlSCpu1tpeh6hRgnByaH9ff1hnvetHUKK2XKzYHjuJZ3Ye62-_QeiTSlWiBOftzIMNowFrS8JUG2zHw2kWSC712uHLK68_ZOe3_LbV-t1ALS3m8VHya-W6kqdoFY6BXvUq2f_QbHVTOACfQb-wBQ3D9p90XDBr_NAtHg6xTgDVPVTQmg9AjmCo6u4X-aHU_XjB7idKoys0g0CBLAxNa9ySQNCmp-VIh7SzepXTUGCFSQwNcqAEEtjLGrMKve636163As3XUOze14vL8MrM26fjWrx_0b0emIxeT1bXOMZBOLw56Ru8xvnsTkJcyO3tysmKYvUericrn_DTm87bcic3nTe1DtdYKQ9M3xfrjcGbe43IDrtiddRo9LlUsAtBwCyQXebnfhQ3KzQj0Wky0aS0mwSKFfC2m-Hx6fHZWvJnSzHVWLxVfulSdvQsk7MSJqsxuzKHYZuZfiurCqJHbLdFhjR4hV7a0sYNjZ1uoZaabqPnptnpz220ZR917h5YrvMvr1G3NmEXu6UJu7UJuzJ3pVuasGtN2M20UGXCb9DwrDs46bdtZ492wgWft3EqaEplwqTImJJEZBkP_ETglDHFWUY8EccpTgJKqc8EeAzlKa6wIrp7AdQcO2hjOpuqXeQGigqshKQqE6zDGNTHNOVe7GWxjDtx6qCj8olGiaW9191XJlFR_hIvsiqIrAocdFBdcG8YX9aL7oKKIjmCeBwNb4hGAXQgAPpcOGin0Ft1C1IwKQnsoP0lRTYEjBU5aK_UbGR9TR4RDNdCsu076GN1FgKBfrsnp2q2ABEoJjyK8XoJ5nPdWpyul4DwLxj3QeKtMan6CQTE9wJOHPTZ2Fh1RvPTn46_h9HsYRRNxgsNGoUy7t3f_uceelF7iPdoY_6wUB8gwZ_H-3b8_AGKdvkr |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurokinin+1+Receptor+Antagonism+as+a+Possible+Therapy+for+Alcoholism&rft.jtitle=Science+%28American+Association+for+the+Advancement+of+Science%29&rft.au=GEORGE%2C+David+T&rft.au=GILMAN%2C+Jodi&rft.au=GEHLERT%2C+Donald+R&rft.au=TAUSCHER%2C+Johannes+T&rft.date=2008-03-14&rft.pub=American+Association+for+the+Advancement+of+Science&rft.issn=0036-8075&rft.volume=319&rft.issue=5869&rft.spage=1536&rft.epage=1539&rft_id=info:doi/10.1126%2Fscience.1153813&rft.externalDBID=n%2Fa&rft.externalDocID=20192204 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0036-8075&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0036-8075&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0036-8075&client=summon |